Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552798 · ClinicalTrials.gov registry record · Phase 3
Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache
A Phase 3 study, sponsored by Bayer.
- Terminated
- Registry status
- Phase 3
- Development phase
- 9
- Enrollment target
NCT01552798: Clinical Trial Phase 3 study, sponsored by Bayer.
NCT01552798 is a Phase 3 study that was terminated before completion, run by Bayer. The registered enrollment target is 9 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01552798, a Phase 3 study, was terminated before completion, sponsored by Bayer.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine if a single, oral dose of a fast release aspirin 1000 mg provides relief compared to acetaminophen 1000 mg and placebo in subjects with tension-type headache pain.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Acetylsalicylic acid (Aspirin, BAY1019036)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-03-12 |
| Est. Completion | 2012-06-04 |
| Phase | Phase 3 |
Why NCT01552798 stopped before completion
NCT01552798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01552798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01552798 about?
NCT01552798 is a clinical study titled "Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache". The purpose of this trial is to determine if a single, oral dose of a fast release aspirin 1000 mg provides relief compared to acetaminophen 1000 mg and placebo in subjects with tension-type headache pain.
What is the current status of trial NCT01552798?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2012-03-12. Estimated completion is 2012-06-04.
What interventions are being tested in trial NCT01552798?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Acetylsalicylic acid (Aspirin, BAY1019036) (DRUG).
Who is sponsoring clinical trial NCT01552798?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01552798's enrollment target sits among peer trials
9 1992nd of 2000 higher than 8 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI